Lifecore Biomedical, Inc. (LFCR) Insider Trading Activity

NASDAQ$6.42
Market Cap
$243.36M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
622 of 849
Rank in Industry
34 of 48

LFCR Insider Trading Activity

LFCR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk …

Insider Activity of Lifecore Biomedical, Inc.

Over the last 12 months, insiders at Lifecore Biomedical, Inc. have bought $0 and sold $0 worth of Lifecore Biomedical, Inc. stock.

On average, over the past 5 years, insiders at Lifecore Biomedical, Inc. have bought $4.1M and sold $9.87M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 17,000 shares for transaction amount of $97,580 was made by Josephs Paul (Chief Executive Officer) on 2025‑01‑08.

List of Insider Buy and Sell Transactions, Lifecore Biomedical, Inc.

2025-05-28SaleEnglish Aron R.10 percent owner
150,419
0.4194%
$7.12
$1.07M
+4.93%
2025-05-27SaleEnglish Aron R.10 percent owner
1.14M
2.8597%
$6.50
$7.41M
+3.43%
2025-05-23SaleEnglish Aron R.10 percent owner
96,137
0.261%
$6.75
$649,386
+7.74%
2025-05-13SaleEnglish Aron R.10 percent owner
12,334
0.0336%
$7.00
$86,353
+4.17%
2025-05-12SaleEnglish Aron R.10 percent owner
45,698
0.1244%
$7.03
$321,426
+3.72%
2025-05-09SaleEnglish Aron R.10 percent owner
700
0.0019%
$7.00
$4,900
+3.87%
2025-05-08SaleEnglish Aron R.10 percent owner
5,098
0.014%
$7.00
$35,693
+5.08%
2025-05-07SaleEnglish Aron R.10 percent owner
15,847
0.0429%
$7.01
$111,099
+3.43%
2025-05-06SaleEnglish Aron R.10 percent owner
701
0.0019%
$7.05
$4,940
+4.17%
2025-05-05SaleEnglish Aron R.10 percent owner
24,543
0.0669%
$7.08
$173,831
+3.13%
2025-01-08PurchaseJosephs PaulChief Executive Officer
17,000
0.0456%
$5.74
$97,580
+20.26%
2024-10-03PurchaseKiper Christopher S
1.46M
2.1987%
$4.10
$6M
+45.44%
2024-10-03PurchaseWYNNEFIELD PARTNERS SMALL CAP VALUE LP I10 percent owner
292,683
0.4397%
$4.10
$1.2M
+45.44%
2022-11-25PurchaseWYNNEFIELD PARTNERS SMALL CAP VALUE LP Idirector
627,746
1.8334%
$7.97
$5M
-14.58%
Total: 14

Insider Historical Profitability

24.14%
Kiper Christopher S
4084268
10.7748%
$26.22M10
+45.44%
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I10 percent owner
2607433
6.8787%
$16.74M20
+15.43%
Josephs PaulChief Executive Officer
559717
1.4766%
$3.59M10
+20.26%

Historical Insider Profitability vs. Competitors

$2,101,005
2135
-11.51%
$64.58M
$131,310,609
62
26.99%
$107.44M
$2,767,882
51
8.70%
$24.78M
$33,884,330
45
12.56%
$223.45M
$98,035,963
43
-10.97%
$486.79M

LFCR Institutional Investors: Active Positions

Increased Positions53+51.46%1M+4.29%
Decreased Positions39-37.86%558,714-2.3%
New Positions19New332,797New
Sold Out Positions14Sold Out189,165Sold Out
Total Postitions117+13.59%25M+2%

LFCR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Wynnefield Capital Inc$36,403.0012.71%4.7M00%2025-09-30
Legion Partners Asset Management, Llc$34,535.0012.06%4.46M+30,000+0.68%2025-09-30
Greenhaven Road Investment Management, L.P.$28,598.009.99%3.69M00%2025-09-30
325 Capital Llc$16,737.005.85%2.16M00%2025-09-30
Blackrock, Inc.$14,247.004.97%1.84M-34,184-1.82%2025-09-30
Vanguard Group Inc$12,560.004.39%1.62M+12,851+0.8%2025-09-30
Geode Capital Management, Llc$5,988.002.09%773,629-1,864-0.24%2025-09-30
Grizzlyrock Capital, Llc$5,719.002%738,882+4,349+0.59%2025-09-30
Morgan Stanley$5,493.001.92%709,699-30,109-4.07%2025-09-30
State Street Corp$4,174.001.46%539,284+8,243+1.55%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.